Cochrane Abstracts
Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bisphosphonates or RANK‐ligand‐inhibitors for Men With Prostate Cancer and Bone Metastases: a Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis.
Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis. Accessed April 18, 2025.
Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis
Bisphosphonates or RANK‐ligand‐inhibitors for Men With Prostate Cancer and Bone Metastases: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis
ID - 434640
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434640/all/Bisphosphonates_or_RANK‐ligand‐inhibitors_for_men_with_prostate_cancer_and_bone_metastases:_a_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
